| scholarly article | Q13442814 |
| P2093 | author name string | K Sugita | |
| M Mizuno | |||
| J Yoshida | |||
| T Takaoka | |||
| P2860 | cites work | Mechanism of lymphocyte-mediated cytotoxicity | Q39834076 |
| Intratumor administration of beta-interferon in recurrent malignant gliomas. A phase I clinical and laboratory study | Q40766702 | ||
| Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease | Q40779573 | ||
| Immune surveillance and tumors of the nervous system | Q40901483 | ||
| Reinforced cytotoxicity of lymphokine-activated killer cells toward glioma cells by transfection with the tumor necrosis factor-alpha gene | Q41576337 | ||
| Growth inhibition of glioma cells transfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody | Q41710577 | ||
| Monoclonal antibody-dependent, cell-mediated cytotoxicity against human malignant gliomas | Q41729993 | ||
| Preliminary trial of specific targeting therapy against malignant glioma | Q41885657 | ||
| ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells | Q44528252 | ||
| Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial | Q44905240 | ||
| Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. Preliminary report | Q48349024 | ||
| Clinical effect of intra-arterial tumor necrosis factor-alpha for malignant glioma | Q48459739 | ||
| Effect of the expression of transforming growth factor-beta 2 in primary human glioblastomas on immunosuppression and loss of immune surveillance | Q48489150 | ||
| The immune system and the nervous system | Q48852534 | ||
| Activation and adhesion molecule expression on lymphoid infiltrates in human glioblastomas | Q48914081 | ||
| Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expression on human glioblastoma cells | Q48947415 | ||
| Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. | Q55484963 | ||
| Intratumoral LAK cell and interleukin-2 therapy of human gliomas. | Q55485579 | ||
| Analysis of T cell subsets in patients with malignant brain tumors. | Q55486056 | ||
| Cytotoxic response of cultured tumor infiltrating lymphocytes to autologous human glioblastoma cells. | Q55486614 | ||
| Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1) | Q68202545 | ||
| Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor | Q69667755 | ||
| P433 | issue | 7 | |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 750-755 | |
| P577 | publication date | 1994-07-01 | |
| P1433 | published in | Japanese Journal of Cancer Research | Q26842384 |
| P1476 | title | Transfection-induced tumor necrosis factor-alpha increases the susceptibility of human glioma cells to lysis by lymphokine-activated killer cells: continuous expression of intercellular adhesion molecule-1 on the glioma cells. | |
| P478 | volume | 85 |
| Q43474904 | Adenovirus-mediated gene transduction of IkappaB or IkappaB plus Bax gene drastically enhances tumor necrosis factor (TNF)-induced apoptosis in human gliomas |
| Q40638336 | Autologous adjuvant linked fibroblasts induce anti-glioma immunity: implications for development of a glioma vaccine |
| Q55479487 | Cytolysis of malignant glioma cells by lymphokine-activated killer cells combined with anti-CD3/antiglioma bifunctional antibody and tumor necrosis factor-alpha. |
| Q41505299 | Growth inhibition of subcutaneously transplanted human glioma by transfection-induced tumor necrosis factor-alpha and augmentation of the effect by gamma-interferon |
Search more.